|
Flumazenil
API (DMF filed) |
|
|
|
Haorui supplies high quality Flumazenil API produced by our
GMP facility that has been successfully inspected by the
FDA.
We offer
competitive prices and support our products with reliable technical and
regulatory services.
Flumazenil API is available from R&D to
commercial quantities. Please contact us for more details. |
| |
|
The following
information is provided for general information purposes
ONLY. |
|
|
|
What is flumazenil?
|
|
Flumazenil is a medicine
used to reverse the effects of benzodiazepines.
Benzodiazepines (diazepam and temazepam) are often used
to induce sedation prior to minor surgical procedures.
|
|
Flumazenil reverses the
effects of benzodiazepines by competing with them for
the GABA receptors. Flumazenil binds to the receptors,
preventing benzodiazepines from acting on them. This
blocks their effects and causes sedation to be reversed.
|
|
|
|
How does flumazenil work?
|
|
The benzodiazepines work by
acting on receptors in the brain (GABA receptors)
causing the release of a chemical called GABA (gamma
amino butyric acid). GABA is a major inhibitory chemical
in the brain involved in inducing sleep and control of
anxiety and fits. Benzodiazepines act by increasing the
activity of GABA, thereby reducing the functioning of
certain areas of the brain. This results in sleepiness,
a decrease in anxiety and relaxation of muscles.
Flumazenil is used to
reverse general anaesthesia induced by benzodiazepines,
sedation induced by benzodiazepines for short term
procedures and sedation of patients in intensive care.
|
|
|
|
Flumazenil chemical formula |
|
Chemically, flumazenil is
ethyl
8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a)(1,4)
benzodiazepine-3-carboxylate. Flumazenil has an
imidazobenzodiazepine structure and calculated molecular
weight of 303.3.
|
|
|
|
What is flumazenil for?
|
|
Flumazenil reverses the
sedative effects of certain medications. It is used to
counteract effects of certain anesthetics. It may also
be used in the treatment of drug overdose.
|
|
|
|
Uses of flumazenil
|
|
Complete or partial reversal
of benzodiazepine-induced depression of the ventilatory
responses to hypercapnia and hypoxia. Situations include
cases where general anesthesia has been induced or
maintained by benzodiazepines, where sedation has been
produced by benzodiazepines for diagnostic and
therapeutic procedures, and for the management of
benzodiazepine overdosage.
|
|
|
|
Contraindications of
flumazenil
|
|
Use in clients given a
benzodiazepine for control of intracranial pressure or
status epilepticus. In clients manifesting signs of
serious cyclic antidepressant overdose. Use during labor
and delivery or in children as the risks and benefits
are not known. To treat benzodiazepine dependence or for
the management of protracted benzodiazepine abstinence
syndrome. Use until the effects of neuromuscular
blockade have been fully reversed.
|
|
|
|
Potential flumazenil side
effects
|
|
Headache, sweating, irritation at the injection site,
blurred vision, flushing, nausea, vomiting or dizziness
may occur. If any of these effects continue or become
bothersome, inform your doctor. Notify your doctor
immediately if you develop a rapid heart rate, skin
rash, mood changes, irritability, anxiety, mental
confusion, nervousness, tremor, abnormal or jerky muscle
movements or depression while taking flumazenil. Avoid
intake of alcoholic beverages or any prescription or
nonprescription medication for at least one day unless
directed to do so by your doctor. Be aware that sedation
may persist and that your memory and judgment may be
impaired for up to one day. Therefore, avoid driving and
do not perform tasks requiring alertness until you no
longer feel dizzy.
Deaths
have occurred in clients receiving flumazenil,
especially in those with serious underlying disease or
in those who have ingested large amounts of
nonbenzodiazepine drugs (usually cyclic antidepressants)
as part of an overdose.
Seizures
are the most common serious flumazenil side effect
noted.
|
|
|
|
Precautions for taking flumazenil
|
|
Tell your doctor if you have
a history of seizures, panic attacks, alcohol or drug
dependency, breathing disorders, heart disease, liver
disease, head injury or if you have any allergies. This
drug should be used only if clearly needed during
pregnancy. Discuss the risks and benefits with your
doctor. It is not known if flumazenil appears in breast
milk. Consult your doctor before breast-feeding. This
drug is not recommended for use in children.
|
|
|
|
Flumazenil should not be used
if you are allergic to one or any of its ingredients.
Please inform your doctor or pharmacist if you have
previously experienced such an allergy. If you
feel you have experienced an allergic reaction, stop
using flumazenil and inform your doctor or pharmacist
immediately.
|
|
|
|
Pregnancy and breastfeeding
while taking flumazenil
|
|
Certain medicines should not
be used during pregnancy or breastfeeding. However,
other medicines may be safely used in pregnancy or
breastfeeding providing the benefits to the mother
outweigh the risks to the unborn baby.Always inform your
doctor if you are pregnant or planning a pregnancy,
before using any medicine.
|
|
Flumazenil should be used
with caution during pregnancy, and only if the expected
benefit to the mother is greater than any possible risk
to the foetus. Seek medical advice from your doctor.
|
|
Small amounts of flumazenil
may pass into breast milk. Seek medical advice from your
doctor before breastfeeding while using flumazenil.
|
|
|
|
Flumazenil intrinsic clinical properties
|
|
Dentists should be aware
that flumazenil does possess its own intrinsic clinical
properties
|
|
At clinical doses (5 mg),
flumazenil can cause cardiovascular depression and
amnesia
|
|
Flumazenil should be
reserved for use in sedation-related emergencies and not
simply to expedite recovery.
|
|
Patients receiving
flumazenil must be discharged with written post-sedation
instructions into the care of a responsible adult.
|
|
|
|
Special concerns for
flumazenil
|
|
The reversal of benzodiazepine
effects may be associated with the onset of seizures in
certain high-risk clients (e.g., concurrent major
sedative-hypnotic drug withdrawal, recent therapy with
repeated doses of parenteral benzodiazepines, myoclonic
jerking or seizure activity prior to administration of
flumazenil in cases of overdose, and concurrent cyclic
antidepressant overdosage). Use with caution in clients
with head injury as the drug may precipitate seizures or
alter cerebral blood flow in clients receiving
benzodiazepines. Use with caution in clients with
alcoholism and other drug dependencies due to the
increased frequency of benzodiazepine tolerance and
dependence. Use with caution during lactation.
|
|
Flumazenil may precipitate a
withdrawal syndrome if the client is dependent on
benzodiazepines. Flumazenil may cause panic attacks in
clients with a history of panic disorder.
|
|
Use with caution in mixed-drug
overdosage as toxic effects (e.g., cardiac dysrhythmias,
convulsions) may occur (especially with cyclic
antidepressants).
|
|
|
|
How can flumazenil affect
other medicines?
|
|
Flumazenil blocks the effects
of benzodiazepines in the brain and also blocks the
effects of non-benzodiazepines, such as zopiclone, which
act at the same receptors.
|
|
|
|
Warning!
|
|
As benzodiazepines have
potential for dependance when used long term, symptoms
of benzodiazepine withdrawal such as depression,
nervousness, rebound insomnia, sweating and irritability
may occur with flumazenil if patients have been treated
with high doses of benzodiazepines for prolonged
periods. This may also occur mildly if benzodiazepine
treatment is reversed after a short period.
|
|
People who have received
flumazenil should not drive or operate machinary for at
least 24 hours after treatment, as the effect of the
benzodiazepine may return temporarily, decreasing mental
and physical ability.
|
|
Flumazenil
Clinical trials
Flumazenil Patents 1
Flumazenil Patents 2 |
|
Flumazenil Patents 3
Flumazenil Patents 4
Flumazenil Patents 5 |
|
Disclaimer:
|
|
Information on this page is
provided for general information purposes. You should
not make a clinical treatment decision based on
information contained in this page without consulting
other references including the package insert of the
drug, textbooks and where relevant, expert opinion. We
cannot be held responsible for any errors you make in
administering drugs mentioned on this page, nor for use
of any erroneous information contained on this page.
|
|
|